Event
2022 Global Conference on Regulatory Science
Tuesday, October 11, 2022
Virtual
hits_regsci@hms.harvard.edu
https://hmcrs.org/event/global-conference/
On Tuesday, October 11, the Harvard-MIT Center for Regulatory Science will host the 2022 Global Conference on Regulatory Science: Evolving Use of Real-World Evidence in Therapeutic Development and Regulation.
This event will feature plenary presentations and panel discussions to learn how real-world evidence is informing regulatory decision-making and advancing knowledge throughout the product lifecycle. Diverse stakeholders will discuss real-world evidence frameworks and use cases in the following areas:
- Drug development and approval in rare conditions
- Demonstration projects
- Post-market evidence generation for medical devices
- Patient community perspective
Speakers include a keynote presentation from Carla Rodriguez-Watson (Director of Research, Reagan-Udall Foundation), Sebastian Schneeweiss (Brigham and Women's Hospital), Gracy Crane (Roche), Marni Hall (IQVIA), Sanket Dhruva (University of California San Francisco), Paul Coplan (Johnson & Johnson), and Sandra Siami (NEST Coordinating Center).
Additional information will be shared online as details are announced. Please also see the event flyer (PDF) for more information.
Additional information will be shared online as details are announced. Please also see the event flyer (PDF) for more information.
Hosted annually by the Harvard-MIT Center for Regulatory Science, the Global Conference on Regulatory Science convenes academic scientists, international regulators, biopharma experts and patient groups to explore emerging topics at the intersection of regulatory science and therapeutic development.
